EIT Health: Stefanie Fluckiger-Mangual (CH)

Award Category: 
EIT Venture

Nominated by

EIT Health

The company

Tolremo is based in Switzerland. 

The innovation

TOLREMO wants to make personalised cancer therapies even more personal and thereby long-lasting. By combining classic mutational information with novel transcriptional information, defining the exact pattern of genes expressed in that particular cancer, we design and velop combination therapies that will prevent the development of drug resistance.









Social Media